Checking in on some valuation rankings, BioDelivery Sciences International, Inc. (NasdaqCM:BDSI) has a Value Composite score of 87. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 90.
In terms of EBITDA Yield, BioDelivery Sciences International, Inc. (NasdaqCM:BDSI) currently has a value of -0.026872. This value is derived by dividing EBITDA by Enterprise Value.
Leverage Ratio
The Leverage Ratio of BioDelivery Sciences International, Inc. (NasdaqCM:BDSI) is 0.565144. Leverage ratio is the total debt of a company divided by total assets of the current and past year divided by two. Companies take on debt to finance their day to day operations. The leverage ratio can measure how much of a company’s capital comes from debt. With this ratio, investors can better estimate how well a company will be able to pay their long and short term financial obligations.
Watching some historical volatility numbers on shares of BioDelivery Sciences International, Inc. (NasdaqCM:BDSI), we can see that the 12 month volatility is presently 46.847600. The 6 month volatility is 48.006500, and the 3 month is spotted at 40.981500. Following volatility data can help measure how much the stock price has fluctuated over the specified time period. Although past volatility action may help project future stock volatility, it may also be vastly different when taking into account other factors that may be driving price action during the measured time period.
Scores
The Gross Margin Score is calculated by looking at the Gross Margin and the overall stability of the company over the course of 8 years. The score is a number between one and one hundred (1 being best and 100 being the worst). The Gross Margin Score of BioDelivery Sciences International, Inc. (NasdaqCM:BDSI) is 68.00000. The more stable the company, the lower the score. If a company is less stable over the course of time, they will have a higher score.
|
Just-released report names Cannabis Stock of the Year for 2019! Their last pick has seen a +1,200% return since he released it! This stock has all of the makings of the next great cannabis stock – early-mover advantage, international exposure and influential partnerships, plus it has a product that is unlike anything else on the market… You will also receive a free, weekly newsletter to stay on top of the latest industry trends, read analysis on promising cannabis stocks, and more. Click here to receive your Free Report immediately! |
M-Score (Beneish)
The M-Score, conceived by accounting professor Messod Beneish, is a model for detecting whether a company has manipulated their earnings numbers or not. BioDelivery Sciences International, Inc. (NasdaqCM:BDSI) has an M-Score of -2.835412. The M-Score is based on 8 different variables: Days’ sales in receivables index, Gross Margin Index, Asset Quality Index, Sales Growth Index, Depreciation Index, Sales, General and Administrative expenses Index, Leverage Index and Total Accruals to Total Assets. A score higher than -1.78 is an indicator that the company might be manipulating their numbers.
Piotroski F-Score
The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a company’s stock is valuable or not. The Piotroski F-Score of BioDelivery Sciences International, Inc. (NasdaqCM:BDSI) is 4. A score of nine indicates a high value stock, while a score of one indicates a low value stock. The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings. It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue. The score is also determined by change in gross margin and change in asset turnover.
Return on Assets
There are many different tools to determine whether a company is profitable or not. One of the most popular ratios is the “Return on Assets” (aka ROA). This score indicates how profitable a company is relative to its total assets. The Return on Assets for BioDelivery Sciences International, Inc. (NasdaqCM:BDSI) is -0.523830. This number is calculated by dividing net income after tax by the company’s total assets. A company that manages their assets well will have a higher return, while a company that manages their assets poorly will have a lower return.
ERP5 Rank
The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of BioDelivery Sciences International, Inc. (NasdaqCM:BDSI) is 16347. The lower the ERP5 rank, the more undervalued a company is thought to be.
